Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1984-07-05
1986-03-18
Rollins, Alton D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
560330, 514399, 548336, 548341, 548262, A61K 3141, A61K 31415, C07D23361, C07D24908
Patent
active
045769575
ABSTRACT:
N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]ureas which are inhibitors of thromboxane synthetase enzyme.
REFERENCES:
patent: 3478039 (1969-11-01), Bell
patent: 3892764 (1975-07-01), Metzger et al.
patent: 4353921 (1982-10-01), Diamond et al.
patent: 4482558 (1984-11-01), Richardson et al.
patent: 4489089 (1984-12-01), Wright et al.
Marsico, Jr. Joseph W.
Press Jeffery B.
Wright, Jr. William B.
American Cyanamid Company
Conroy, Jr. Edward A.
Rollins Alton D.
LandOfFree
N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-tria does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-tria, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-(Substituted phenyl)-N'-[(1H-imidazol-1-yl) and (1H-1,2,4-tria will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2306369